TETRALOGIC PHARMACEUTICALS CORP 4
4 · TETRALOGIC PHARMACEUTICALS CORP · Filed Dec 19, 2013
Insider Transaction Report
Form 4
Meyers Peter A.
CFO & Treasurer
Transactions
- Award
Stock Option
2013-12-17$7.00/sh+164,394$1,150,758→ 487,888 totalExercise: $7.00Exp: 2023-12-17→ Common Stock (164,394 underlying) - Purchase
Common Stock
2013-12-17$7.00/sh+142,857$999,999→ 142,857 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the options or 41,098 options vested at the closing of the Company's initial public offering on 12/17/13; the balance of the options become exercisable at the rate of 3,424 options per month until all of the options are vested with 3,456 vested in the final month. Vesting ceases if the employee is no longer an active full-time employee of the Company on the vesting date. If there is a change of control as defined in the Company's 2013 Equity Plan, the entire unvested portion of the shares shall become immediately vested.